Director, Clinical Research, Division of Lymphoma
Dana-Farber Cancer Institute (DFCI)
Boston, MA, United States
Dr. Matthew Davids is a Boston native and serves as the Director of Clinical Research in the Division of Lymphoma at Dana-Farber Cancer Institute and as an Associate Professor of Medicine at Harvard Medical School in Boston. In the field of chronic lymphocytic leukemia, he cares for patients, leads innovative clinical trials with targeted agents, and runs a translational research lab focused on identifying new combination approaches and elucidating resistance mechanisms to targeted therapies in this disease.
Friday, October 6, 2023
9:05 AM – 9:10 AM EDT
Friday, October 6, 2023
1:00 PM – 1:10 PM EDT
Session 5: Optimizing Initial Therapy of CLL
Sunday, October 8, 2023
8:15 AM – 9:55 AM EDT
Sunday, October 8, 2023
12:15 PM – 12:25 PM EDT
Sunday, October 8, 2023
12:25 PM – 12:35 PM EDT
Future Research Priorities and Unmet Needs in CLL: A Roundtable Discussion and Audience Q&A
Monday, October 9, 2023
3:50 PM – 4:55 PM EDT